Hypoxia-induced mitogenic factor (HIMF) is a newly discovered protein that is up-regulated in murine models of pulmonary arterial hypertension and asthma. Our previous study shows that HIMF is a potent mitogenic, angiogenic, and vasoconstrictive chemokine associated with pulmonary arterial hypertension. Two-dimensional gel electrophoresis was used to investigate downstream molecules in HIMF-induced cell signaling, demonstrating that S100A11, an EF-hand calcium-binding protein, was exclusively altered and was decreased (2.7 ؎ 0.2-fold, p < 0.05) in pulmonary artery smooth muscle cells (SMCs) treated with HIMF for 5 min compared with untreated cells (n ؍ 4). Immunofluorescence showed that in control cells S100A11 is a cytosolic protein, which then aggregates and translocates both to the plasma membrane with subsequent exocytosis and to the nucleus upon HIMF stimulation. Annexin A2, a known S100A11 binding partner, also colocalized with S100A11 during HIMF-induced membrane trafficking. To investigate the intracellular function of S100A11, siRNA was used to knock down S100A11 expression in SMCs. The S100A11 knockdown significantly reduced HIMF-induced SMC migration but did not affect the SMC mitogenic action of HIMF. Our data show that S100A11 mediates HIMF-induced smooth muscle cell migration, vesicular exocytosis, and nuclear activation.Molecular & Cellular Proteomics 10: 10.1074/mcp. M110.000901, 1-7, 2011.
The family of "resistin-like molecule (RELM)1 /found in inflammatory zone (FIZZ)" proteins comprises a group of proteins with a conserved motif of 10 equally spaced cysteine residues within the C terminus. Hypoxia-induced mitogenic factor (HIMF), one member of the murine RELM/FIZZ family, is also known as RELM␣ because of its similarity to resistin (1) and FIZZ1 for its prominent presence in inflammatory lung of a murine model of allergic asthma (2). We have previously reported that HIMF is up-regulated in a mouse chronic hypoxia-induced model of pulmonary arterial hypertension (PAH) (3); that it has mitogenic, angiogenic, vasoconstrictive, antiapoptotic, and chemokine-like properties (3, 4); and that its overexpression can induce the vascular and hemodynamic changes of PAH (5). HIMF can stimulate multiple cell signaling pathways, but understanding of its molecular actions in the cell remains limited (3-5). For example, in bone marrow-derived mesenchymal cells, HIMF can bind Bruton's tyrosine kinase (BTK), induce BTK autophosphorylation, and cause redistribution of BTK to the leading edge of the cells (6). HIMF has chemotactic actions on myeloid cells via BTK (6). As well, HIMF can activate Akt phosphorylation via the phosphatidylinositol 3-kinase (PI3K)-Akt pathway in pulmonary smooth muscle cells (SMCs) (3). It also activates the phosphorylation of ERK 1/2 via the mitogen-activated protein kinase (MAPK) pathway. More recently, we found that HIMF can stimulate the mobilization of intracellular calcium via the phospholipase C-inositol trisphosphate pathway in pulmonary SMCs. This calcium mobilization is inde...